Forte Biosciences (FBRX) Interest Expenses (2016 - 2020)
Forte Biosciences (FBRX) reported Interest Expenses of $756000.0 for Q1 2020, little changed year-over-year from $754000.0 in Q2 2019, and up 129.09% quarter-over-quarter from $330000.0 in Q4 2019.
Forte Biosciences (FBRX) Interest Expenses (2016 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has 5 years of Interest Expenses data on file, last reported at $756000.0 in Q1 2020.
- Interest Expenses for Q1 2020 came in at $756000.0, changed 0.27% year-over-year; the trailing twelve-month figure through Dec 2020 was $756000.0 (down 80.21% YoY), and the FY2019 annual result was $3.8 million, up 30.38% from the prior year.
- Interest Expenses grew to $756000.0 in Q1 2020 per FBRX's latest filing, from $330000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $2.0 million in Q3 2019 and troughed at $330000.0 in Q4 2019.
- A 5-year average of $675941.2 and a median of $533000.0 in 2016 frame the typical range for Interest Expenses.
- On a YoY basis, Interest Expenses climbed as much as 165.9% in 2019 and fell as far as 55.76% in 2019.
- A 5-year view of Interest Expenses shows it stood at $533000.0 in 2016, then fell by 26.64% to $391000.0 in 2017, then surged by 90.79% to $746000.0 in 2018, then sank by 55.76% to $330000.0 in 2019, then surged by 129.09% to $756000.0 in 2020.
- Business Quant data shows FBRX's Interest Expenses at $756000.0 in Q1 2020, $330000.0 in Q4 2019, and $2.0 million in Q3 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Forte Biosciences | 70.77 Mn | 12.55 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 756,000.00 |
| Mar 31, 2020 | 756,000.00 |
| Dec 31, 2019 | 330,000.00 |
| Dec 31, 2019 | 330,000.00 |
| Sep 30, 2019 | 1.97 Mn |
| Sep 30, 2019 | 1.97 Mn |
| Jun 30, 2019 | 764,000.00 |
| Jun 30, 2019 | 764,000.00 |
| Mar 31, 2019 | 754,000.00 |
| Mar 31, 2019 | 754,000.00 |
| Dec 31, 2018 | 746,000.00 |
| Dec 31, 2018 | 746,000.00 |
| Sep 30, 2018 | 742,000.00 |
| Sep 30, 2018 | 742,000.00 |
| Jun 30, 2018 | 1.09 Mn |
| Jun 30, 2018 | 1.09 Mn |
| Mar 31, 2018 | 349,000.00 |
| Mar 31, 2018 | 349,000.00 |
| Dec 31, 2017 | 391,000.00 |
| Dec 31, 2017 | 391,000.00 |